SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-026801
Filing Date
2019-11-06
Accepted
2019-11-06 17:25:28
Documents
2
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2756
2 EX-24 DOCUMENT attachment1.htm EX-24 4316
  Complete submission text file 0000899243-19-026801.txt   8471
Mailing Address GLAXOSMITHKLINE THREE FRANKLIN PLAZA, 1600 VINE STREET PHILADELPHIA PA 19102
Business Address
LOKAY KEVIN G (Reporting) CIK: 0001211256 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 191197351

Mailing Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations